Published in Clin Lab Haematol on January 01, 1983
Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction) Blood (1996) 6.36
Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol (Oxf) (1979) 4.42
Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet (1986) 4.04
Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5' non-coding region. Nucleic Acids Res (1986) 3.86
Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med (1995) 3.60
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest (2007) 3.58
Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature (2000) 2.84
Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase. EMBO J (1986) 2.64
Glucose-6-phosphate dehydrogenase deficient red cells: resistance to infection by malarial parasites. Science (1969) 2.21
Increased sickling of parasitised erythrocytes as mechanism of resistance against malaria in the sickle-cell trait. Lancet (1970) 2.11
A transgenic mouse model of sickle cell disorder. Nature (1990) 2.05
Adaptation of Plasmodium falciparum to glucose 6-phosphate dehydrogenase-deficient host red cells by production of parasite-encoded enzyme. Nature (1985) 2.04
Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc Natl Acad Sci U S A (2001) 1.99
TbetaR-I(6A) is a candidate tumor susceptibility allele. Cancer Res (1999) 1.99
Blood group antigens and antibodies in Nigeria. Ann Trop Med Parasitol (1974) 1.94
Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. J Clin Invest (1997) 1.86
Glucose-6-phosphate dehydrogenase and malaria. Greater resistance of females heterozygous for enzyme deficiency and of males with non-deficient variant. Lancet (1972) 1.83
Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J (1994) 1.80
Comparison of GdA and GdB activities in Nigerians. A study of the variation of the G6PD activity. Am J Hum Genet (1977) 1.79
Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East. Am J Hum Genet (1990) 1.75
Specific methylation pattern at the 3' end of the human housekeeping gene for glucose 6-phosphate dehydrogenase. EMBO J (1984) 1.75
Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U S A (1999) 1.75
Mechanism of action of streptomycin in E. coli: interruption of the ribosome cycle at the initiation of protein synthesis. Proc Natl Acad Sci U S A (1968) 1.72
Genetics of red cells and susceptibility to malaria. Blood (1979) 1.71
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma. Eur J Nucl Med (2001) 1.70
cDNA sequences of human glucose 6-phosphate dehydrogenase cloned in pBR322. Nature (1981) 1.69
Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res (1998) 1.68
High-level, erythroid-specific expression of the human alpha-globin gene in transgenic mice and the production of human hemoglobin in murine erythrocytes. Genes Dev (1989) 1.63
The international reference preparation of erythropoietin. Bull World Health Organ (1966) 1.60
In vivo telomere dynamics of human hematopoietic stem cells. Proc Natl Acad Sci U S A (1997) 1.58
Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells. Blood (1970) 1.57
Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell (1997) 1.54
The heart in eosinophilic leukaemia. Afr J Med Sci (1970) 1.54
Optic nerve involvement in acute lymphoblastic leukemia. Leuk Lymphoma (1993) 1.52
Indolent cutaneous prodrome of fatal HTLV-I infection. Lancet (1990) 1.48
Polymerase chain reaction automated at low cost. Nucleic Acids Res (1988) 1.46
Serum erythropoietin levels in paroxysmal nocturnal haemoglobinuria: implications for therapy. Br J Haematol (1996) 1.38
Purchasing research from or for the NHS? J R Coll Physicians Lond (1995) 1.38
Glucose-6-phosphate dehydrogenase. Adv Hum Genet (1985) 1.38
A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management. J Thromb Haemost (2012) 1.35
Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria. Lancet (1994) 1.34
Paroxysmal nocturnal haemoglobinuria. Baillieres Clin Haematol (1989) 1.34
The molecular basis of glucose-6-phosphate dehydrogenase deficiency. Trends Genet (1992) 1.33
Parental occupation and other environmental factors in the etiology of leukemias and non-Hodgkin's lymphomas in childhood: a case-control study. Tumori (1990) 1.33
Different properties of glucose 6-phosphate dehydrogenase from human erythrocytes with normal and abnormal enzyme levels. Biochem Biophys Res Commun (1965) 1.33
Cytological mapping of the human glucose-6-phosphate dehydrogenase gene distal to the fragile-X site suggests a high rate of meiotic recombination across this site. Proc Natl Acad Sci U S A (1984) 1.30
Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood (1992) 1.30
Red cell glucose-6-phosphate dehydrogenase status and pyruvate kinase activity in a Nigerian population. Trop Med Int Health (2000) 1.24
Genetic factors in malaria. Bull World Health Organ (1974) 1.24
Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen. J Immunol Methods (1987) 1.21
Pregnancy in homozygous sickle-cell anaemia. J Obstet Gynaecol Br Commonw (1972) 1.21
Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates. Br J Haematol (1982) 1.19
Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding alpha-mannosidase II. Proc Natl Acad Sci U S A (1990) 1.19
G6PD Mediterranean accounts for the high prevalence of G6PD deficiency in Kurdish Jews. Hum Genet (1993) 1.17
Variants of glucose-6-phosphate dehydrogenase are due to missense mutations spread throughout the coding region of the gene. Hum Mutat (1993) 1.15
Human erythrocyte glucose 6-phosphate dehydrogenase: structure and function in normal and mutant subjects. Curr Top Hematol (1978) 1.14
[Prevention, diagnosis, therapy, and follow-up of lung cancer]. Pneumologie (2010) 1.14
DNA rearrangements of immunoglobulin genes correlate with phenotypic markers in B-cell malignancies. Mol Biol Med (1984) 1.13
Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Br J Haematol (1999) 1.13
Imbalance in X-chromosome expression: evidence for a human X-linked gene affecting growth of hemopoietic cells. Science (1979) 1.13
Two populations of erythroid cell progenitors in paroxysmal nocturnal hemoglobinuria. Blood (1984) 1.13
Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study. Leukemia (2004) 1.13
Analysis of beta, gamma, and delta T-cell receptor genes in mycosis fungoides and Sezary syndrome. Cancer (1991) 1.12
Both mutations in G6PD A- are necessary to produce the G6PD deficient phenotype. Hum Mol Genet (1992) 1.12
Polyribosome depletion and blockage of the ribosome cycle by streptomycin in Escherichia coli. J Mol Biol (1969) 1.12
Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A (1993) 1.11
Relationship between the genes for glucose-6-phosphate dehydrogenase and for haemoglobin in a Nigerian population. Nature (1968) 1.11
The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib. Leukemia (2013) 1.11
Two autologous transplants in the treatment of patients with Hodgkin's lymphoma: analysis of prognostic factors and comparison with a single procedure. Leuk Lymphoma (2007) 1.11
Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood (2000) 1.10
Decreased malaria morbidity in the Tharu people compared to sympatric populations in Nepal. Ann Trop Med Parasitol (1988) 1.10
Dyskeratosis and ribosomal rebellion. Nat Genet (1998) 1.10
Paroxysmal nocturnal hemoglobinuria. Semin Hematol (1989) 1.10
Genetic heterogeneity of "normal" human erythrocyte glucose-6-phosphate dehydrogenase: an isoelectrophoretic polymorphism. Proc Natl Acad Sci U S A (1979) 1.10
Mild spherocytic hereditary elliptocytosis and altered levels of alpha- and gamma-adducins in beta-adducin-deficient mice. Blood (2000) 1.09
Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis (1997) 1.08
Glucose 6-phosphate dehydrogenase deficiency and sickle cell anemia: frequency and features of the association in an African community. Blood (1975) 1.08
Heterogeneity of T-cell beta-chain gene rearrangements in human leukaemias and lymphomas. EMBO J (1985) 1.08
Retroviral-mediated gene transfer of a mutant H-ras gene into normal human bone marrow alters myeloid cell proliferation and differentiation. Exp Hematol (1994) 1.07
An extensive search for RFLP in the human glucose-6-phosphate dehydrogenase locus has revealed a silent mutation in the coding sequence. Am J Hum Genet (1988) 1.07
Enzymic properties of different types of human erythrocyte glucose-6-phosphate dehydrogenase, with characterization of two new genetic variants. J Clin Invest (1968) 1.07
Tissue-specific levels of human glucose-6-phosphate dehydrogenase correlate with methylation of specific sites at the 3' end of the gene. Proc Natl Acad Sci U S A (1985) 1.07
Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation. Bone Marrow Transplant (2003) 1.06
Regulation of the activity of glucose-6-phosphate dehydrogenase by NADP+ and NADPH. Biochim Biophys Acta (1967) 1.06
Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie (2010) 1.06
Genetic variation in the host and adaptive phenomena in Plasmodium falciparum infection. Ciba Found Symp (1983) 1.05
Development of the immune response in the foetal and newborn rhesus monkey. I. Response to bovine serum albumin. Immunology (1966) 1.05
Rhesus immunization in Nigeria. Vox Sang (1968) 1.05
Studies of polymorphic traits for the characterization of populations. African populations south of the Sahara. Isr J Med Sci (1974) 1.05
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine. Eur J Cancer (2004) 1.04
G6PD Canton a common deficient variant in South East Asia caused by a 459 Arg----Leu mutation. Nucleic Acids Res (1990) 1.04
Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia. Blood (1997) 1.04